Press Release Vaximm AG, an OSR Company, Announces Forthcoming Publication of Cross-Indication Clinical Data for VXM01, Its VEGFR-2-Targeted Cancer Vaccine Platform 8 hours ago
Press Release OSR Health Secures Nasdaq Communication: Loyalty CVR Program Will Not Trigger a Price Adjustment Jul 31